Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

NCT05046613 · clinicaltrials.gov ↗
RECRUITING
Status
780
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer

Collaborators